| Specification |
30% |
Usage |
Antibiotic |
| Raw Material |
Oxytetracycline base |
Species |
Cattle, sheep, swine, camels,chicken |
| Dosage Form |
Injection |
Sample |
Yes |
| Packing |
100ml/vial/box, 80boxes/carton
100ml/vial/box, 120boxes/carton |
Delivery Time |
15-20days |
| MOQ |
500L |
Payment Term |
T/T, D/P, D/A, L/C |
| GMP |
Yes |
ISO9001 |
Yes |
| FDA |
Yes |
COS |
Yes |
Product Description
COMPOSITION
Each 1 ml contains:
Oxytetracycline base.......300 mg
INDICATIONS
Oxytetracycline injection 30% is intended for use in treatment for the following diseases when due to oxytetracycline-susceptible organisms: Beef cattle, non-lactating dairy cattle, calves, including pre-ruminating (veal) calves.
Oxytetracycline injection 30% is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp., and Histophilus spp.
Oxytetracycline injection 30% is indicated for the treatment of infectious bovine keratoconjunctivitis (pink eye) caused by Moraxella bovis, foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococcal and streptococcal organisms sensitive to oxytetracycline.
MODE OF ADMINISTRATION
By deep Intramuscular injection or Subcutaneous injection
DOSAGE:
Cattle, Sheep:
Standard Dose: 20mg/kg (1ml/15kg)
High Dose: 30mg/kg (1ml/10kg)
Maximum recommended dosage at one site:
Cattle 15ml
Sheep 5 ml
Although Oxytetracycline injection 30% is well tolerated, occasionally a slight local reaction of a transient nature may be observed.
The use of oxytetracyclines during the period of tooth and bone development, including late pregnancy, may lead to discolouration.
Oxytetracycline therapy does not completely eliminate chlamydial infection in a flock. If concurrent treatment is administered use a separate injection site.
WITHDRAWAL PERIOD
Meat: Animals must not be slaughtered for human consumption during treatment.
20 mg/kg dose: Cattle and sheep after 28 days from the last treatment.
30 mg/kg dose: Cattle after 35 days from the last treatment.
Sheep after 28 days from the last treatment.
Milk: 10 days.
PRECAUTIONS:
Exceeding the highest recommended level of drug per kilogram of bodyweight per day, administering more than the recommended number of treatments, and/or exceeding 1 mL intramuscularly or subcutaneously per injection site in adult beef cattle and non-lactating dairy cattle, may result in antibiotic residues beyond the withdrawal time.
Consult with your veterinarian prior to administering this product in order to determine the proper treatment required in the event of an adverse reaction. At the first sign of any adverse reaction, discontinue use of the product and seek the advice of your veterinarian. Some of the reactions may be attributable either to anaphylaxis (an allergic reaction) or to cardiovascular collapse of unknown cause.
Shortly after injection treated animals may have transient hemoglobinuria resulting in darkened urine.
STORAGE:
Protect from direct sunlight and store below 30°C.
Company Profile
Hebei Veyong pharmaceutical Co., Ltd., was established in 2002, located in Shijiazhuang City Hebei Province, China, near the Capital Beijing. It's a large GMP-certified veterinary druo enterprise, with R&D, production and sales of veterinary APlspreparations premixed feeds and feed additives. As Provincial Technical CenterVeyong has established an innovated R&D system for new veterinary drug, and is the nationally knowntechnological innovation-based veterinary enterprise. Veyong has two production bases: Shijiazhuang and Ordos, with 7APl production lines including lvermectin, Eprinomectin, Tiamulin Fumarateects and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant ect. Veyong provides APls, more than 100 own-label preparations and OEM & ODM service
Vevong established the comolete auality manaement svstem, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technica service, has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong attaches great importance to the management of EHS (Environment Health & Safety) system, and obtained the lSO14001 and OHSAS18001 certificates. Veyong ha been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply ofproducts.
Vevong takes "Maintain animal health, improve quality of life"as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
Prodution workshop:
Warehouse:
Laboratory:
Audited Supplier 
){kind=link}